CME Group Inc. (NASDAQ:CME) Shares Sold by Creative Planning

Creative Planning cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 46,901 shares of the financial services provider’s stock after selling 1,411 shares during the period. Creative Planning’s holdings in CME Group were worth $9,221,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company increased its stake in CME Group by 4.1% in the 4th quarter. The Manufacturers Life Insurance Company now owns 270,453 shares of the financial services provider’s stock valued at $56,957,000 after buying an additional 10,750 shares during the period. NEOS Investment Management LLC boosted its holdings in shares of CME Group by 29.4% in the fourth quarter. NEOS Investment Management LLC now owns 6,056 shares of the financial services provider’s stock valued at $1,275,000 after acquiring an additional 1,376 shares in the last quarter. Capital International Investors boosted its holdings in shares of CME Group by 0.4% in the fourth quarter. Capital International Investors now owns 12,739,369 shares of the financial services provider’s stock valued at $2,683,012,000 after acquiring an additional 50,626 shares in the last quarter. Capital International Ltd. CA increased its stake in shares of CME Group by 18.4% during the fourth quarter. Capital International Ltd. CA now owns 61,784 shares of the financial services provider’s stock worth $13,012,000 after acquiring an additional 9,585 shares during the period. Finally, Capital International Sarl lifted its position in CME Group by 20.4% in the fourth quarter. Capital International Sarl now owns 84,663 shares of the financial services provider’s stock valued at $17,830,000 after purchasing an additional 14,320 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Stock Performance

CME Group stock opened at $225.28 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $225.32. The stock has a fifty day moving average of $210.67 and a two-hundred day moving average of $207.48. The company has a market capitalization of $81.12 billion, a price-to-earnings ratio of 25.63, a PEG ratio of 8.74 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.30 EPS. On average, analysts anticipate that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s payout ratio is currently 52.33%.

Analyst Ratings Changes

CME has been the topic of several recent analyst reports. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Finally, Royal Bank of Canada assumed coverage on shares of CME Group in a research report on Friday, September 27th. They set a “sector perform” rating and a $235.00 target price on the stock. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average target price of $212.54.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.